Akebia Therapeutics (AKBA) Misses Q2 EPS by 17c

August 8, 2019 8:07 AM

Akebia Therapeutics (NASDAQ: AKBA) reported Q2 EPS of ($0.49) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found